CD4 and cancer: The results demonstrated that the scores of CD4_Tcells and B_cells were significantly higher in the low risk score group, suggesting that the high activity of these immune cell types in the low-risk group may play a key role in activating the immune system, killing tumor cells, and inhibiting cancer progression (Fig. 7B).